Management of inflammatory breast cancer

Prof Ghosn speaks with ecancer at the 10th BGICC in Cairo about diagnosis and treatment of inflammatory breast cancers in North Africa.

He describes the changing rate of disease development in the region, and molecular markers that may speed diagnosis and guide treatment.

Prof Ghosn notes a high mutational load in locally advanced tumours, with p53 among commonly associated genes, and the potential impact of checkpoint therapies in disease management once trial data becomes available.